Becker's Healthcare January 17, 2023
Private equity has weaved its way into ASCs, and healthcare experts don’t expect it to go anywhere.
Three healthcare leaders connected with Becker’s to answer, “What does 2023 have in store for the ASC industry?”
Editor’s note: Responses have been lightly edited for length and clarity.
Trishul Kapoor, MD. House Officer and CSTAR Fellow in the Department of Anesthesiology at the University of Michigan Medicine (Ann Arbor): The current U.S. ASC market is valued at greater than $36B and is expected to surpass $144B by 2032. This is certainly not a surprising prediction considering the growing surgical needs of patients age 65 or older in the U.S. This subset of the U.S. patient population has grown by 18 million over...
Today's Sponsors
Today's Sponsor